Perrigo Plc (PRGO) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Perrigo Company Plc  (NYSE: PRGO)
 

Perrigo Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Perrigo Company Plc inventory turnover ratio, the Perrigo Company Plc's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.43 in the second quarter 2026, yet the ratio remained below the average, as PRGO's market remain challenging.Average inventory processing period, for the Perrigo Plc in Jun 27 2026 quarter, has decreased to 150 days, compare to 156 days, in the Mar 28 2026 quarter.

Within Healthcare sector 162 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 909 in the first quarter 2026, to 1462.

PRGO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Perrigo Company Plc Market Share?

What is Inventory Turnover Ratio?




PRGO Inventory Turnover Ratio (Jun 27 2026)
II. Quarter
(Mar 28 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Inventory Growth -12.42 % -2.91 % 6.21 % 8.22 % 8.9 %
Y / Y Cost of Sales Growth 2.24 % -1.23 % 0.66 % -2.49 % 3.49 %
Inventory Turnover Ratio (TTM) 2.43 2.34 2.33 2.36 2.43
PRGO's Total Ranking # 1462 # 909 # 879 # 621 #
Average inventory processing period 150 156 156 155 151
Seq. Inventory Growth -5.07 % -2.4 % -6.36 % 0.95 % 5.24 %
Seq. Cost of Sales Growth 10.25 % -15.17 % 13.81 % -3.95 % 6.51 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 43
Healthcare Sector # 163
Overall Market # 1462

Inventory Turnover Ratio Statistics
High Average Low
5.07 2.95 1.61
(Dec 27 2014)   (Dec 31 2015)




Financial Statements
Perrigo Plc's Inventories $ 1,065 Millions Visit PRGO's Balance sheet
Perrigo Plc's Cost of Revenues TTM $ 2,776 Millions Visit PRGO's Income Statement
What are PRGO's Sales? Visit PRGO's Sales by Segment

Other Inventory Turnover Ratios
Perrigo Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PRGO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PRGO's Competitors
Inventory Turnover Ratio for PRGO's Suppliers
Inventory Turnover Ratio for PRGO's Customers

You may also want to know
PRGO's Sales Growth Rates PRGO's Pe Price to earnings ratio PRGO's Receivables Turnover Ratio PRGO's Stock Quote
PRGO's Net Income Growth Rates PRGO's Ps Price to Sales ratio PRGO's Sales per Employee PRGO's Asset Turnover Ratio
PRGO's Net Margin PRGO's Pb Price to Book ratio PRGO's Financial Strength Ratios PRGO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 27 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 27 2026 Inventories at quarter ending Jun 27 2026
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Precision Optics Corporation Inc   6.97 $ 26.101  Millions$ 4  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Edap Tms Sa  6.05 $ 60.703  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Bristol myers Squibb Company  5.37 $ 14,678.000  Millions$ 2,735  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Integrated Biopharma Inc  4.50 $ 41.768  Millions$ 9  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.